- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.12.25 | Scandinavian Real Heart AB: Realheart resolves on a rights issue of SEK 70 million | 89 | GlobeNewswire (Europe) | NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE OR DISTRIBUTION... ► Artikel lesen | |
| 16.12.25 | Scandinavian Real Heart AB: Bulletin from the Extraordinary General Meeting in Scandinavian Real Heart AB (publ) on 16 December 2025 | 71 | GlobeNewswire (Europe) | Scandinavian Real Heart AB (publ) held an Extraordinary General Meeting on December 16, 2025. All decisions were made in accordance with the proposals set out in the notice.
Resolutions at the General... ► Artikel lesen | |
| 27.11.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 27.11.2025 | 642 | Xetra Newsboard | Das Instrument B0M SGXE21011833 ALPINA HOLDINGS EQUITY wird cum Kapitalmassnahme gehandelt am 27.11.2025 und ex Kapitalmassnahme am 28.11.2025 The instrument B0M SGXE21011833 ALPINA HOLDINGS EQUITY... ► Artikel lesen | |
| 05.11.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approvals in Key Asian Markets | 158 | GlobeNewswire (Europe) | Västerås, Sweden, November 5, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approvals in China and Japan. The patents concern both the core technology... ► Artikel lesen | |
| 26.09.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approval in Japan | 315 | GlobeNewswire (Europe) | Västerås, Sweden, September 26, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the Japan Patent Office (JPO) concerning the automatic control... ► Artikel lesen | |
| SCANDINAVIAN REAL HEART Aktie jetzt für 0€ handeln | |||||
| 17.09.25 | Scandinavian Real Heart AB: Realheart Publishes Positive Blood Flow Data Using a Groundbreaking 4D Medical Imaging Method | 272 | GlobeNewswire (Europe) | Västerås, Sweden, September 17, 2025 - Scandinavian Real Heart AB (publ) announces today that the company and its academic partner at Linköping University has published results from a scientific study... ► Artikel lesen | |
| 28.08.25 | Scandinavian Real Heart AB: Interim Report April - June 2025 | 255 | GlobeNewswire (Europe) | Summary of Interim Report April - June 2025Group Overview2025-04-012024-04-012025-01-012024-01-012024-01-012025-06-302024-06-302025-06-302024-06-302024-12-313 mon3 mon6 mon6 mon12 monOperating income20... ► Artikel lesen | |
| 17.06.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approval in the US | 313 | GlobeNewswire (Europe) | Västerås, Sweden, June 17, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted patent approval by the United States Patent and Trademark Office (USPTO) concerning... ► Artikel lesen | |
| 12.06.25 | Scandinavian Real Heart AB: Bulletin From the Annual General Meeting of Scandinavian Real Heart AB on June 12, 2025 | 277 | GlobeNewswire (Europe) | Scandinavian Real Heart AB (the "Company") has today, June 12, 2025, held its annual general meeting where the following resolutions were made.
Adoption of the Income Statement and Balance Sheet, Appropriation... ► Artikel lesen | |
| 15.05.25 | Scandinavian Real Heart AB: Interim Report January - March 2025 | 331 | GlobeNewswire (Europe) | Summary of Interim Report January - March 2025
Group Overview2025-01-012024-01-012024-01-012025-03-312024-03-312024-12-313 mon3 mon12 monOperating income69 99410 05850 054Earnings after financial items-9... ► Artikel lesen | |
| 29.04.25 | Scandinavian Real Heart AB: Realheart Receives Patent Approval in Japan | 306 | GlobeNewswire (Europe) | Västerås, Sweden, April 29, 2025 - Scandinavian Real Heart AB (publ) announces today that the company has been granted a patent approval by the Japan Patent Office (JPO) concerning a pressure sensor... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 287,95 | +2,77 % | ROUNDUP/Aktien New York: Kaum verändert am vorletzten Handelstag des Jahres | NEW YORK (dpa-AFX) - Bei den wichtigsten US-Aktienindizes hat sich am Dienstag am vorletzten Handelstag des Jahres wenig getan. Der Dow Jones Industrial sank im frühen Handel um 0,08 Prozent auf 48.423... ► Artikel lesen | |
| INMODE | 12,700 | +0,32 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 12,500 | -0,79 % | Dividendenbekanntmachungen (31.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,2 USD 0,1702 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1802 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,310 | -1,36 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,100 | -1,62 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 47,770 | -2,47 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,360 | -1,60 % | EILMELDUNG: Carl Zeiss Meditec-Aktie stabil - Marktbeobachter rechnen mit Bewegung. | ||
| ECKERT & ZIEGLER | 15,050 | -1,38 % | ECKERT & ZIEGLER SE - Stabilität als strategische Basis | ||
| GERRESHEIMER | 27,820 | +0,87 % | Comeback 2026! Verzehnfachung möglich? Evotec, Gerresheimer, Desert Gold Aktie! | Auf der Suche nach einem möglichen Verzehnfacher im Gold-Sektor? Dies halten Analysten bei Desert Gold für möglich. Die jüngste PEA für das Flaggschiff-Gold-Projekt löst neue Kursfantasie aus. Damit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 37,560 | +0,29 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| GENEDX | 136,44 | +4,91 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,020 | +1,32 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| OTTOBOCK | 65,75 | +0,77 % | IPO-Rückblick 2025: TKMS, Klarna, Ottobock und Circle im Anleger-Check | Guten Tag, liebe Leserinnen und Leser,
2025 war ein vergleichsweise starkes Jahr für Neuemissionen. Allein in der ersten Jahreshälfte wagten weltweit 539 Unternehmen den Schritt an die Börse und sammelten... ► Artikel lesen | |
| PROGYNY | 25,910 | +0,86 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,755 | -5,08 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen |
SCANDINAVIAN REAL HEART AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 2,340 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDINAVIAN REAL HEART AB finden Sie auf Wallstreet Online.